ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

CD Formulation Unveils Its Latest Offering: A Comprehensive Line of Pharmaceutical Formulation Characterization Testing Services

By: Get News

New York, USA - April 25, 2023 - The need for high-quality pharmaceutical development services has never been more pressing. Therefore, in a swift response to such demand, CD Formulation has recently rolled out its new Pharmaceutical Formulation Characterization Testing (PFCT) services, a move aiming to help ensure that the newly developed pharmaceutical products are stable, effective, and in compliance with the regulatory requirements.

Backed by laboratories equipped with state-of-the-art equipment and trained scientists familiar with the latest analytical techniques and methodologies, CD Formulation can conduct PFCT services most effectively. The company has a proven track record of delivering high-quality pharmaceutical formulation development services to clients across the globe. Meanwhile, the new services are expected to help pharmaceutical companies develop safe and effective drugs more quickly and efficiently, ultimately benefiting patients and improving outcomes.

"The PFCT services are an integral part of our company's overall mission to improve patient outcomes through innovative pharmaceutical formulation development solutions," said the Marketing Chief of CD Formulation. "We're committed to delivering the highest level of quality and accuracy in all of our services, and the launch of its PFCT services is a testament to this commitment."

In addition to its new PFCT services, CD Formulation also offers cost-effective pharmaceutical formulation development services for various dosage forms. The company's expertise in formulation development sets it apart from other providers, as it enables clients to benefit from a streamlined and efficient development process.

"The launch of PFCT services comes at a time when the pharmaceutical industry is under increased scrutiny for its drug development practices. In recent years, there have been numerous instances of pharmaceutical companies releasing drugs that were later found to be unsafe or ineffective," the Chief further added.

Featured offering of CD Formulation's PFCT services:

Chromatographic Analysis of Pharmaceutical Preparations

• Infrared Absorption Spectrometry Analysis of Pharmaceutical Preparations

• Mass Spectrometry Analysis of Pharmaceutical Preparations

• NMR Spectroscopy Analysis Services in Pharmaceuticals

Thermal Analysis Services for Drug Composition Identification

• Thermal Platform Microscope Analysis of Pharmaceutical Preparations

• X-Ray Diffraction Analysis Services for Drug Molecules

Please visit the website https://www.formulationbio.com to learn more.

About CD Formulation

With a commitment to excellence and a focus on innovation, CD Formulation is a trusted partner for pharmaceutical companies and researchers around the world owing to its advanced analytical tools, state-of-the-art facilities, and a team of experts. As the pharmaceutical industry continues to evolve and face new challenges, CD Formulation continues to make itself an ideal choice for anyone seeking top-quality pharmaceutical analysis and testing services.

Media Contact
Company Name: CD Formulation
Contact Person: Helen Smith
Email: Send Email
Phone: 1-631-372-1052
Country: United States
Website: https://www.formulationbio.com



Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.